Compound Q&A
What are the main uses of Deruxtecan (CAS: 1599440-13-7)?
Answer
Deruxtecan is primarily used as a treatment for patients with advanced or metastatic solid tumors, particularly those expressing the nectin-4 antigen. It is approved for use in certain types of breast cancer, lung cancer, and other cancers. Deruxtecan is administered intravenously and acts by selectively delivering cytotoxic payload to cancer cells expressing nectin-4.
About
CAS No
1599440-13-7
English Name
Deruxtecan
Molecular Formula
C52H56FN9O13
Molecular Weight
1034.07 g/mol
SMILES
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cc(c(c6c5c4[C@H](CC6)NC(=O)COCNC(=O)CNC(=O)[C@H](Cc7ccccc7)NC(=O)CNC(=O)CNC(=O)CCCCCN8C(=O)C=CC8=O)C)F)O
InChIKey
WXNSCLIZKHLNSG-MCZRLCSDSA-N
Last Updated: 2025-12-24 21:16
